Dr. Christina GY obtained her Ph.D. from Monash University in 2012, where she explored candidate early predictors for diabetic nephropathy. Her doctoral research hypothesized CYP2E1 as a potential biomarker for assessing the risk of diabetic nephropathy.
Building on her Ph.D. work, Dr. Christina pursued postdoctoral research, developing a targeted proteomic approach to quantify CYP2E1 in human blood samples. Her work focused on evaluating the applicability of this analytical method in clinical practice, contributing to advancements in early disease detection.
Her research interests include the role of early biomolecules in metabolic syndromes, the study of drug-metabolizing enzymes, and the impact of obesity on metabolic health. She possesses extensive expertise in HPLC, LC-MS/MS, genomics (microarray analysis using Genespring and Partek), proteomics, metabolomics, bioinformatics, as well as animal and cell culture models.
Currently, Dr. Christina serves as an Associate Professor of Biomedical Sciences at the School of Medicine, Monash University Malaysia, where she plays a key role in medical and health sciences education. She teaches Problem-Based Learning (PBL), Histology, Physiology, and Pharmacology in the Doctor of Medicine (MD) and Bachelor of Human Nutrition programs.